Analyst Ratings for Parabilis Medicines (PBLS)
PBLS Rating Summary
PBLS Price Target Summary
- Highest: $45.00 (BofA Securities)
- Lowest: $40.00 (Guggenheim)
- Average: $41.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.67 (+40.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$41.67 (+40.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/6/2026 | BofA Securities | Tazeen Ahmad | New Coverage | Buy (N/A) |
45.00 (N/A) |
29.58 (29.58) |
0% | Details |
| 7/6/2026 | Leerink | Andrew Berens | New Coverage | Outperform (N/A) |
40.00 (N/A) |
29.58 (29.58) |
0% | Details |
 |
||||||||
|
||||||||
